List of Figures

FIGURE 1 RESEARCH DESIGN 26
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE DESIGNATION, AND REGION 29
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 31
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 31
FIGURE 5 DATA TRIANGULATION 32
FIGURE 6 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT AND SERVICE, 2018 VS. 2023 34
FIGURE 7 MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2018 VS. 2023 35
FIGURE 8 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018 VS. 2023 36
FIGURE 9 MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2018 VS. 2023 37
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE MOLECULAR DIAGNOSTICS MARKET 38
FIGURE 11 INCREASING PREVALENCE OF INFECTIOUS DISEASES AND VARIOUS TYPES
OF CANCERS ? KEY DRIVERS FOR THE MARKET 39
FIGURE 12 PCR TECHNOLOGY TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2018 40
FIGURE 13 REAGENTS AND KITS TO DOMINATE THE MOLECULAR DIAGNOSTICS MARKET
IN 2023 40
FIGURE 14 HOSPITAL AND ACADEMIC LABORATORIES TO ACCOUNT FOR THE LARGEST
SHARE IN 2018 41
FIGURE 15 MOLECULAR DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES 42
FIGURE 16 DNA SEQUENCING & NGS TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD (2018–2023) 59
FIGURE 17 GEOGRAPHICAL SNAPSHOT: ASIA PACIFIC TO BE THE FASTEST-GROWING REGIONAL SEGMENT IN THE MOLECULAR DIAGNOSTICS MARKET 117
FIGURE 18 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT 119
FIGURE 19 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT 144
FIGURE 20 COMPANIES ADOPTED PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY OVER THE LAST THREE YEARS 173
FIGURE 21 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2017 174
FIGURE 22 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET RANKING, BY KEY
PLAYER, 2017 175
FIGURE 23 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR PCR, MARKET SHARE
ANALYSIS, BY KEY PLAYER 2016 176
FIGURE 24 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING
AND NGS, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016 176
FIGURE 25 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR ISH, BY KEY PLAYER, 2016 177
FIGURE 26 ABBOTT LABORATORIES: COMPANY SNAPSHOT 180
FIGURE 27 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT 184
FIGURE 28 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 189
FIGURE 29 BIOM?RIEUX SA: COMPANY SNAPSHOT 194
FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT 198
FIGURE 31 DIASORIN: COMPANY SNAPSHOT 203
?
FIGURE 32 GRIFOLS: COMPANY SNAPSHOT 207
FIGURE 33 HOLOGIC: COMPANY SNAPSHOT 210
FIGURE 34 ILLUMINA: COMPANY SNAPSHOT 213
FIGURE 35 QIAGEN: COMPANY SNAPSHOT (2017) 217
FIGURE 36 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 222
FIGURE 37 SIEMENS AG: COMPANY SNAPSHOT 226
FIGURE 38 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 229

 

List of Tables

TABLE 1 NEW TESTS LAUNCHED BY KEY PLAYERS 45
TABLE 2 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 48
TABLE 3 MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET, BY REGION 2016–2023 (USD MILLION) 48
TABLE 4 NORTH AMERICA: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET BY COUNTRY, 2016–2023 (USD MILLION) 49
TABLE 5 EUROPE: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET BY COUNTRY/REGION, 2016–2023 (USD MILLION) 49
TABLE 6 ASIA PACIFIC: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET BY COUNTRY/REGION, 2016–2023 (USD MILLION) 50
TABLE 7 ROW: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET, BY REGION 2016–2023 (USD MILLION) 50
TABLE 8 LATIN AMERICA: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET BY COUNTRY/REGION, 2016–2023 (USD MILLION) 50
TABLE 9 MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION 2016–2023 (USD MILLION) 51
TABLE 10 NORTH AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET BY COUNTRY, 2016–2023 (USD MILLION) 52
TABLE 11 EUROPE: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET BY COUNTRY/REGION, 2016–2023 (USD MILLION) 52
TABLE 12 ASIA PACIFIC: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET BY COUNTRY/REGION, 2016–2023 (USD MILLION) 53
TABLE 13 ROW: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION 2016–2023 (USD MILLION) 53
TABLE 14 LATIN AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET BY COUNTRY/REGION, 2016–2023 (USD MILLION) 53
TABLE 15 MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET, BY REGION 2016–2023 (USD MILLION) 54
TABLE 16 NORTH AMERICA: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET BY COUNTRY, 2016–2023 (USD MILLION) 55
TABLE 17 EUROPE: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET BY COUNTRY/REGION, 2016–2023 (USD MILLION) 55
TABLE 18 ASIA PACIFIC: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET BY COUNTRY/REGION, 2016–2023 (USD MILLION) 56
TABLE 19 ROW: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET BY REGION, 2016–2023 (USD MILLION) 56
TABLE 20 LATIN AMERICA: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET BY COUNTRY/REGION, 2016–2023 (USD MILLION) 57
TABLE 21 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 60
TABLE 22 MOLECULAR DIAGNOSTICS MARKET FOR PCR, BY REGION 2016–2023 (USD MILLION) 61
TABLE 23 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR PCR BY COUNTRY, 2016–2023 (USD MILLION) 61
TABLE 24 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR PCR, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 61
TABLE 25 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR PCR BY COUNTRY/REGION, 2016–2023 (USD MILLION) 62
TABLE 26 ROW: MOLECULAR DIAGNOSTICS MARKET FOR PCR, BY REGION 2016–2023 (USD MILLION) 62
TABLE 27 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR PCR BY COUNTRY/REGION, 2016–2023 (USD MILLION) 63
TABLE 28 MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY REGION 2016–2023 (USD MILLION) 63
TABLE 29 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INAAT BY COUNTRY, 2016–2023 (USD MILLION) 64
TABLE 30 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR INAAT BY COUNTRY/REGION, 2016–2023 (USD MILLION) 64
TABLE 31 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR INAAT BY COUNTRY/REGION, 2016–2023 (USD MILLION) 65
TABLE 32 ROW: MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY REGION 2016–2023 (USD MILLION) 65
TABLE 33 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INAAT BY COUNTRY/REGION, 2016–2023 (USD MILLION) 65
TABLE 34 MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS BY REGION, 2016–2023 (USD MILLION) 66
TABLE 35 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA
SEQUENCING AND NGS, BY COUNTRY, 2016–2023 (USD MILLION) 67
TABLE 36 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING
AND NGS, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 67
TABLE 37 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING
AND NGS, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 68
TABLE 38 ROW: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS BY REGION, 2016–2023 (USD MILLION) 68
TABLE 39 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING
AND NGS, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 68
TABLE 40 MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY REGION, 2016–2023 (USD MILLION) 69
TABLE 41 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2016–2023 (USD MILLION) 70
TABLE 42 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION BY COUNTRY/REGION, 2016–2023 (USD MILLION) 70
TABLE 43 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION BY COUNTRY/REGION, 2016–2023 (USD MILLION) 71
TABLE 44 ROW: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION BY REGION, 2016–2023 (USD MILLION) 71
TABLE 45 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 71
TABLE 46 MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY, BY REGION 2016–2023 (USD MILLION) 72
TABLE 47 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY BY COUNTRY, 2016–2023 (USD MILLION) 72
TABLE 48 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY BY COUNTRY/REGION, 2016–2023 (USD MILLION) 73
TABLE 49 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY BY COUNTRY/REGION, 2016–2023 (USD MILLION) 73
TABLE 50 ROW: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY, BY REGION, 2016–2023 (USD MILLION) 74
TABLE 51 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY BY COUNTRY/REGION, 2016–2023 (USD MILLION) 74
TABLE 52 MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016–2023 (USD MILLION) 75
TABLE 53 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2023 (USD MILLION) 75
TABLE 54 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES BY COUNTRY/REGION, 2016–2023 (USD MILLION) 76
TABLE 55 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES BY COUNTRY/REGION, 2016–2023 (USD MILLION) 76
TABLE 56 ROW: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES BY REGION, 2016–2023 (USD MILLION) 77
TABLE 57 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 77
TABLE 58 MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 79
TABLE 59 MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES BY REGION, 2016–2023 (USD MILLION) 80
TABLE 60 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS
DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 81
TABLE 61 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES BY COUNTRY/REGION, 2016–2023 (USD MILLION) 81
TABLE 62 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES BY COUNTRY/REGION, 2016–2023 (USD MILLION) 82
TABLE 63 ROW: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES BY REGION, 2016–2023 (USD MILLION) 82
TABLE 64 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS
DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 82
TABLE 65 MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY DISEASE TYPE, 2016–2023 (USD MILLION) 83
TABLE 66 HEPATITIS DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 84
TABLE 67 HEPATITIS DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION ASSAYS) 84
TABLE 68 HIV DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 85
TABLE 69 HIV DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION ASSAYS) 85
TABLE 70 CT/NG DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 86
TABLE 71 CT/NG DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION ASSAYS) 86
TABLE 72 HAI DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 87
TABLE 73 HAI DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION ASSAYS) 87
TABLE 74 HPV DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 88
TABLE 75 HPV DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION ASSAYS) 88
TABLE 76 TB DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 89
TABLE 77 TB DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION ASSAYS) 89
TABLE 78 INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 90
TABLE 79 INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION ASSAYS) 90
TABLE 80 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION 2016–2023 (USD MILLION) 91
TABLE 81 MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY REGION 2016–2023 (USD MILLION) 92
TABLE 82 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY BY COUNTRY, 2016–2023 (USD MILLION) 92
TABLE 83 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY BY COUNTRY/REGION, 2016–2023 (USD MILLION) 93
TABLE 84 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY BY COUNTRY/REGION, 2016–2023 (USD MILLION) 93
TABLE 85 ROW: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY REGION 2016–2023 (USD MILLION) 94
TABLE 86 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY BY COUNTRY/REGION, 2016–2023 (USD MILLION) 94
TABLE 87 MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY CANCER TYPE 2016–2023 (USD MILLION) 94
TABLE 88 BREAST CANCER DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 95
TABLE 89 COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION 2016–2023 (USD MILLION) 96
TABLE 90 LUNG CANCER DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 96
TABLE 91 PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION 2016–2023 (USD MILLION) 97
TABLE 92 OTHER CANCER DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 98
TABLE 93 MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING, BY REGION 2016–2023 (USD MILLION) 99
TABLE 94 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING BY COUNTRY, 2016–2023 (USD MILLION) 99
TABLE 95 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING BY COUNTRY/REGION, 2016–2023 (USD MILLION) 100
TABLE 96 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING BY COUNTRY/REGION, 2016–2023 (USD MILLION) 100
TABLE 97 ROW: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING, BY REGION, 2016–2023 (USD MILLION) 101
TABLE 98 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING BY COUNTRY/REGION, 2016–2023 (USD MILLION) 101
TABLE 99 MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 102
TABLE 100 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 102
TABLE 101 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS BY COUNTRY, 2016–2023 (USD MILLION) 103
TABLE 102 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS BY COUNTRY/REGION, 2016–2023 (USD MILLION) 103
TABLE 103 ROW: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 104
TABLE 104 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 104
TABLE 105 MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 106
TABLE 106 MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY REGION, 2016–2023 (USD MILLION) 107
TABLE 107 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL
& ACADEMIC LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION) 108
TABLE 108 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 108
TABLE 109 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 109
TABLE 110 ROW: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY REGION, 2016–2023 (USD MILLION) 109
TABLE 111 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 109
TABLE 112 MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY REGION, 2016–2023 (USD MILLION) 110
TABLE 113 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION) 110
TABLE 114 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY COUNTRY/REGION, 2016–2023 (USD MILLION) 111
TABLE 115 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 111
TABLE 116 ROW: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES BY REGION, 2016–2023 (USD MILLION) 112
TABLE 117 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 112
TABLE 118 MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION 2016–2023 (USD MILLION) 113
TABLE 119 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY, 2016–2023 (USD MILLION) 113
TABLE 120 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY/REGION, 2016–2023 (USD MILLION) 114
TABLE 121 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY/REGION, 2016–2023 (USD MILLION) 114
TABLE 122 ROW: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2016–2023 (USD MILLION) 115
TABLE 123 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS BY COUNTRY/REGION, 2016–2023 (USD MILLION) 115
TABLE 124 MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 118
TABLE 125 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT
& SERVICE, 2016–2023 (USD MILLION) 119
TABLE 126 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 120
TABLE 127 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 120
TABLE 128 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2015–2023 (USD MILLION) 121
TABLE 129 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY 2016–2023 (USD MILLION) 121
TABLE 130 US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 122
TABLE 131 US: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 123
TABLE 132 US: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 123
TABLE 133 US: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 123
TABLE 134 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 124
TABLE 135 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 125
TABLE 136 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 125
TABLE 137 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 126
TABLE 138 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 127
TABLE 139 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 127
TABLE 140 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 128
TABLE 141 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 128
TABLE 142 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION 2016–2023 (USD MILLION) 129
TABLE 143 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 130
TABLE 144 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 130
TABLE 145 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 131
TABLE 146 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 131
TABLE 147 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 132
TABLE 148 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 132
TABLE 149 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 133
TABLE 150 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 133
TABLE 151 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 134
TABLE 152 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 134
TABLE 153 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 135
TABLE 154 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2015–2023 (USD MILLION) 135
TABLE 155 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 136
TABLE 156 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 137
TABLE 157 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 137
TABLE 158 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2015–2023 (USD MILLION) 138
TABLE 159 UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2015–2023 (USD MILLION) 139
TABLE 160 UK: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 139
TABLE 161 UK: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 140
TABLE 162 UK: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 140
TABLE 163 ROE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 141
TABLE 164 ROE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 141
TABLE 165 ROE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 142
TABLE 166 ROE: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 142
TABLE 167 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 144
TABLE 168 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 145
TABLE 169 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 145
TABLE 170 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 146
TABLE 171 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION 2016–2023 (USD MILLION) 146
TABLE 172 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 147
TABLE 173 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 148
TABLE 174 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 148
TABLE 175 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 149
TABLE 176 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 150
TABLE 177 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 150
TABLE 178 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 151
TABLE 179 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 151
TABLE 180 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 152
TABLE 181 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 152
TABLE 182 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 153
TABLE 183 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 153
TABLE 184 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 154
TABLE 185 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 155
TABLE 186 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 155
TABLE 187 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 156
TABLE 188 ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 156
TABLE 189 ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 157
TABLE 190 ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 157
TABLE 191 ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 158
TABLE 192 ROW: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 159
TABLE 193 ROW: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 159
TABLE 194 ROW: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 160
TABLE 195 ROW: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 160
TABLE 196 ROW: MOLECULAR DIAGNOSTICS MARKET, BY REGION 2016–2023 (USD MILLION) 160
TABLE 197 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 161
TABLE 198 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 162
TABLE 199 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 162
TABLE 200 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 163
TABLE 201 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 163
TABLE 202 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 164
TABLE 203 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 164
TABLE 204 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 165
TABLE 205 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 165
TABLE 206 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 166
TABLE 207 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 167
TABLE 208 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 167
TABLE 209 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 168
TABLE 210 ROLA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 2016–2023 (USD MILLION) 168
TABLE 211 ROLA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 2016–2023 (USD MILLION) 169
TABLE 212 ROLA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 2016–2023 (USD MILLION) 169
TABLE 213 ROLA: MOLECULAR DIAGNOSTICS MARKET, BY END USER 2016–2023 (USD MILLION) 170
TABLE 214 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT
& SERVICE, 2016–2023 (USD MILLION) 170
TABLE 215 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 171
TABLE 216 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 171
TABLE 217 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 172
TABLE 218 NEW PRODUCT LAUNCHES AND APPROVALS, 2016–2018 177
TABLE 219 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2016–2018 178
TABLE 220 ACQUISITIONS AND MERGERS 2016–2018 179
TABLE 221 EXPANSIONS, 2016–2018 179